BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 1102083)

  • 21. Chemotherapy studies on experimental mouse tumors. IX.
    French FA; Blanz EJ
    Cancer Chemother Rep 2; 1971 Apr; 2(1):177-97. PubMed ID: 5565535
    [No Abstract]   [Full Text] [Related]  

  • 22. 1,3,2-diazaphosphorine 2-oxides. 3. Preparation and biological evaluation of some 1,3-bis(aralkyl)-2-halo-1,3,2-diazaphosphorine 2-oxides and related compounds.
    Billman JH; Meisenheimer JL; May RF
    J Med Chem; 1966 Sep; 9(5):772-4. PubMed ID: 4291025
    [No Abstract]   [Full Text] [Related]  

  • 23. Antitumour activity of some cyclophosphazenes.
    Labarre JF; Faucher JP; Levy G; Sournies F; Cros S; François G
    Eur J Cancer (1965); 1979 May; 15(5):637-43. PubMed ID: 510331
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of ethidium bromide against transplantable tumors in mice and rats.
    Kramer MJ; Grunberg E
    Chemotherapy; 1973 Oct; 19(4):254-8. PubMed ID: 4801160
    [No Abstract]   [Full Text] [Related]  

  • 25. Antitumor activity of 1-alkoxycarbonylalkylcarbamoyl-5-fluorouracil derivatives by oral administration.
    Iigo M; Hoshi A; Inomata M; Ando N; Kuretani K
    J Pharmacobiodyn; 1981 Mar; 4(3):203-10. PubMed ID: 7252769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ifosfamide in experimental tumor systems.
    Goldin A
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):14-23. PubMed ID: 6761864
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis of potential antineoplastic agents. XIV. Some 2-substituted 2,3-dihydro-1h-perimidines.
    Wasulko W; Noble AC; Popp FD
    J Med Chem; 1966 Jul; 9(4):599-601. PubMed ID: 4165378
    [No Abstract]   [Full Text] [Related]  

  • 28. Screening data from the Caner Chemotherapy National Service Center Screening Laboratories. XXIX.
    Leiter J; Abbott BJ; Schepartz SA
    Cancer Res; 1965 Dec; 25(11 Pt 2):1779-2061. PubMed ID: 5856668
    [No Abstract]   [Full Text] [Related]  

  • 29. The carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. 3. Primary correlation.
    French FA; Blanz EJ
    J Med Chem; 1966 Jul; 9(4):585-9. PubMed ID: 5968028
    [No Abstract]   [Full Text] [Related]  

  • 30. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. III. Antitumor activity of tallysomycins A and B.
    Imanishi H; Ohbayashi M; Nishiyama Y; Kawaguchi H
    J Antibiot (Tokyo); 1978 Jul; 31(7):667-74. PubMed ID: 80402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-antitumor activity relationships among quinone derivatives.
    Driscoll JS; Hazard GF; Wood HB; Goldin A
    Cancer Chemother Rep 2; 1974 Apr; 4(2):1-362. PubMed ID: 4856629
    [No Abstract]   [Full Text] [Related]  

  • 32. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
    Fujimoto S; Ogawa M
    Cancer Chemother Pharmacol; 1982; 9(3):134-9. PubMed ID: 6218931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of cyclocytidine in a variety of tumors.
    Hoshi A; Kanzawa F; Kuretani K
    Gan; 1972 Jun; 63(3):353-60. PubMed ID: 5072834
    [No Abstract]   [Full Text] [Related]  

  • 34. Some new aryl-sydnones: effects on murine tumours.
    Grynberg N; Gomes R; Shinzato T; Echevarria A; Miller J
    Anticancer Res; 1992; 12(3):1025-8. PubMed ID: 1320354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential carcinostatic agents. I. Derivatives and analogs of 1-(2-hydroxyethyl)-3-(4-tolyl)urea.
    Nelson HG; Shelton FJ; Wetzel WH
    J Med Chem; 1967 Jul; 10(4):735-6. PubMed ID: 6037073
    [No Abstract]   [Full Text] [Related]  

  • 36. Potential antitumor agents. Derivatives of 2-hydrazino-5-nitropyridine.
    Prescott B; Caldes G
    J Pharm Sci; 1970 Jan; 59(1):101-4. PubMed ID: 5411311
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antitumor activity of the components of a carminomycin complex].
    Shorin VA; Bazhanov VS; Averbukh LA
    Antibiotiki; 1977 Jan; 22(1):69-74. PubMed ID: 576573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening study on Taiwan plants for antitumor activities.
    King ML; Wang CT; Chang CF; Hsu HM; Wang SJ; Hartwell JL; Abbott BJ
    Cancer Chemother Rep 2; 1974 Jul; 4(3):1-96. PubMed ID: 4842546
    [No Abstract]   [Full Text] [Related]  

  • 39. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The carcinostatic activity of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. II. 3-Hydroxypyridine-2-carboxaldehyde thiosemicarbazone.
    French FA; Blanz EJ
    Cancer Res; 1966 Aug; 26(8):1638-40. PubMed ID: 5923162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.